COMMUNIQUÉS West-GlobeNewswire

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
15/04/2026
Call scheduled for today, Wednesday, April 15, 2026, at 5:00 pm ET LITTLETON, Colo., April 15, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS) , a leading medical device and [...]
Inteleos Foundation Announces 2026 MedMissions Award to Advance Maternal Health Ultrasound Access in Five Nations
15/04/2026
ROCKVILLE, Md., April 15, 2026 (GLOBE NEWSWIRE) -- The Inteleos Foundation today announced five recipients of its 2026 MedMissions Award, supporting maternal health ultrasound access in Malawi, Sierra Leone, Kenya, [...]
Cerene® by Channel Medsystems Partners with Hey Girl! Fund to Support Menstrual Education at Caregivers & Girlies Brunch on Saturday, April 18
15/04/2026
PHILADELPHIA, April 15, 2026 (GLOBE NEWSWIRE) -- Cerene®, developed by Channel Medsystems, a leader in innovative women’s health solutions, is proud to announce its partnership with Hey Girl! Fund 501(c)(3) for the [...]
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
15/04/2026
Travelers can now purchase the only once-weekly, broad-spectrum malaria preventive online, through the Runway Health telehealth platform WASHINGTON, April 15, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. ( [...]
Allogene Therapeutics Announces Nature Communications Publication Highlighting Pre-Clinical Data for ALLO-329, a Next Generation Dual-Targeted CD19/CD70 Allogeneic CAR T for Autoimmune Diseases
15/04/2026
Study Highlights Dagger ® Technology Showing that an Optimized CD70 CAR has the Potential to Protect Against Immune Rejection, Enabling Robust Expansion and Persistence of Allogeneic CAR T Cells in Pre-Clinical Models [...]
BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
15/04/2026
MENLO PARK, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, [...]
Scientific Review Raises Questions About Root Canal Safety and Whole-Body Health
15/04/2026
LAKELAND, Fla., April 15, 2026 (GLOBE NEWSWIRE) -- The International Academy of Oral Medicine and Toxicology (IAOMT) conducted and just released a comprehensive scientific literature review examining the health effects [...]
Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions
15/04/2026
Adare Partnership Provides Supply Chain Redundancy and U.S.-based Manufacturing Capability Company Reiterates Guidance - If Approved, Cytisinicline Commercial Launch Expected in First Half of 2027 SEATTLE and VANCOUVER [...]
Annual General Meeting of Kuros Biosciences approves all resolutions
15/04/2026
Annual General Meeting of Kuros Biosciences approves all resolutions Schlieren (Zurich), Switzerland, April 15, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, [...]
Xenon to Present at Upcoming Investor Conferences
15/04/2026
VANCOUVER, British Columbia and BOSTON, MA, April 15, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical [...]
Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
15/04/2026
Company Designing FDA Application Amendments and U.S. Clinical Strategy Leveraging Extensive Real-World Neurostimulation Data Sets Reflecting Broad Clinical Experiences HOUSTON, TX, April 15, 2026 (GLOBE NEWSWIRE) -- [...]
Ardena Opens New Bioanalytical Laboratory in Somerset, New Jersey
15/04/2026
Somerset, New Jersey, USA – April 15, 2026 – Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces that its new state-of –the-art GLP bioanalytical [...]
NeuraClick Expands Scientific and Translational Leadership with Key Advisory Appointments
15/04/2026
SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- NeuraClick, Inc. , a preclinical-stage biopharmaceutical company developing macrocyclic neuropeptide therapeutics using its proprietary NuClick™ platform, today announced [...]
BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
15/04/2026
MISSISSAUGA, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX), a profitable growth-stage specialty healthcare products company, is pleased to announce that it will be presenting at [...]
Calidi Biotherapeutics Announces Participation in RedChip’s April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
15/04/2026
SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will [...]
HealPort Raises 1.2M USD to Scale Global Digital Health Infrastructure
15/04/2026
MUSCAT, Oman, April 15, 2026 (GLOBE NEWSWIRE) -- HealPort announced that it has raised $1.2 million in funding to accelerate development and deployment of its integrated platforms and supporting infrastructure designed [...]
What if you could reboot sick cells?
15/04/2026
Scientists develop MitoCatch , a system that delivers healthy mitochondria directly to the cells that need them most Basel, 15 April 2026 – Scientists led by Botond Roska at the Institute of Molecular and Clinical [...]
Traws Pharma Announces Up to $60 Million Private Placement Financing
15/04/2026
Financing led by Sirenia Capital Management LP advances Traws Pharma's influenza program through a human challenge trial for tivoxavir marboxil in the United Kingdom NEWTOWN, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- [...]
PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial
15/04/2026
78% Objective Response Rate (ORR) with PDS01ADC; Parallel trial without PDS01ADC had 35% ORR 2-year survival rate of >80%; Parallel trial without PDS01ADC resulted in 2-year survival rate of ~35% Trials performed in [...]

Pages